Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001213900-13-006695
Filing Date
2013-11-19
Accepted
2013-11-19 15:23:07
Documents
1

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS SUPPLEMENT f424b3111913_actinium.htm 424B3 1893831
  Complete submission text file 0001213900-13-006695.txt   1894876
Mailing Address 501 FIFTH AVENUE, 3RD FLOOR NEW YORK NY 10017
Business Address 501 FIFTH AVENUE, 3RD FLOOR NEW YORK NY 10017 212-300-2131
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-191468 | Film No.: 131229837
SIC: 6770 Blank Checks